Arcellx Inc (ACLX) stock news · rev $107.9M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This ACLX news page leads with what Arcellx Inc filed — not a scraped headline mill.
No cached 8-K sentence for ACLX yet. We will not pad this page with generic market recap.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ACLX stock page; for the tape open the quote page.
Not investment advice.